ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,607Medicare Part D Prescriptions Filled, Including Refills

Rank: 941 out of 3722

$717K Total Retail Price of All Prescriptions

Rank: 671 out of 3722

629 Patients Receiving at Least One Drug in Part D
74% Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Florida
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

20% of this provider’s 629 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 414 362 89 1 3
AMLODIPINE BESYLATE 354 274 88 2 2
FUROSEMIDE 273 225 76 3 8
TRAMADOL HCL 261 232 93 4 20
METOPROLOL TARTRATE 237 208 67 5 9
SIMVASTATIN 236 195 63 6 1
PANTOPRAZOLE SODIUM 211 161 65 7 29
LISINOPRIL 210 188 64 8 5
CLOPIDOGREL 210 180 50 8 15
CARVEDILOL 203 160 63 10 22
HYDROCODONE-ACETAMINOPHEN 195 122 59 S3 11 13
WARFARIN SODIUM 184 133 49 12 19
PRAVASTATIN SODIUM 183 167 43 13 17
ATORVASTATIN CALCIUM 180 137 51 14 6
ALPRAZOLAM 172 143 54 B 15 11
OMEPRAZOLE 165 114 51 16 4
HYDRALAZINE HCL 144 112 49 17 78
LOSARTAN POTASSIUM 141 126 36 18 10
ZOLPIDEM TARTRATE 140 135* 30 19 21
METFORMIN HCL 134 97 31 20 7
CRESTOR 121 103 32 21 24
OXYCODONE-ACETAMINOPHEN 119 98 82 S2 22 89
DOXYCYCLINE HYCLATE 113 87 80 23 138
ESCITALOPRAM OXALATE 107 102* 21 24 47
POTASSIUM CHLORIDE 101 89 28 25 23
ZOSTAVAX 101 89 101 25 196
GLYBURIDE 98 74 19 R 27 103
HYDROCHLOROTHIAZIDE 93 88* 25 28 12
GLIPIZIDE 89 66 16 29 38
CLONIDINE HCL 88 72 29 30 49
LYRICA 85 54 18 31 100
CIPROFLOXACIN HCL 77 62 58 32 56
CLONAZEPAM 76 64 15 B 33 52
ISOSORBIDE MONONITRATE ER 75 63 17 34 59
SPIRIVA 75 70* 19 34 92
TAMSULOSIN HCL 74 61 20 36 28
CITALOPRAM HBR 74 57 15 36 30
AZITHROMYCIN 72 59 54 38 40
GABAPENTIN 72 50 26 38 16
METHYLPREDNISOLONE 66 52 53 40 74
DIOVAN 66 <11 <11 40 48
SPIRONOLACTONE 65 60* 18 42 75
METOPROLOL SUCCINATE 64 59* 15 43 18
DONEPEZIL HCL 63 63 12 44 33
LANTUS 62 57* 19 45 68
NOVOLOG 58 53* 11 46 119
CLOTRIMAZOLE-BETAMETHASONE 55 32 28 47 83
PREDNISONE 54 42 28 48 46
LANTUS SOLOSTAR 53 20 13 49 99
DIGOX 52 52 11 50 87
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.